BioSante Pharmaceuticals (BPAX) Reports a Q3 Loss
Tweet Send to a FriendGet Alerts BPAX Hot Sheet
Price: $1.15 --0%
EPS Growth %: -125.0%
Financial Fact:
Research and development: 972.05K
Today's EPS Names:
CSS, STV, GIGM, More
EPS Growth %: -125.0%
Financial Fact:
Research and development: 972.05K
Today's EPS Names:
CSS, STV, GIGM, More
Trade BPAX Now!
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) reports a Q3 loss of $0.16 compared to a loss of $0.21 for the same period last year.
The Company’s cash and cash equivalents as of September 30, 2010 were approximately $35.5 million, as compared to cash and cash equivalents of approximately $29.9 million on December 31, 2009
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Company’s cash and cash equivalents as of September 30, 2010 were approximately $35.5 million, as compared to cash and cash equivalents of approximately $29.9 million on December 31, 2009
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Rexnord (RXN) Misses Q4 EPS by 7c; Issues Light Q1 Outlook
- Home Depot, Inc. (HD) Tops Q1 EPS by 6c; Boosts FY13 Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
